Human Papillomavirus (HPV) News and Research

Latest Human Papillomavirus (HPV) News and Research

New national guidelines for anal cancer prevention in HIV patients based on UCSF research

New recommendations for screening and treatment are based on the results of a major national study led at UCSF.

19 Jul 2024

Global childhood immunization coverage: Stalled progress and growing gaps

Global childhood immunization coverage stalled in 2023, leaving 2.7 million additional children un- and under-vaccinated compared to pre-pandemic levels in 2019, according to data published today by the World Health Organization (WHO) and UNICEF.

15 Jul 2024

40% of US cancer cases linked to lifestyle choices

Nearly 40% of cancer cases and 44% of cancer deaths in 2019 were due to modifiable risk factors, with cigarette smoking as the leading cause. This study highlights the potential to significantly reduce cancer burden through lifestyle changes.

14 Jul 2024

Study: 40% of cancer cases in the U.S. attributable to modifiable risk factors

A new study led by researchers at the American Cancer Society (ACS) finds four in 10 cancer cases and about one-half of all cancer deaths in adults 30 years old and older in the United States (or 713,340 cancer cases and 262,120 cancer deaths in 2019) could be attributed to modifiable risk factors, including cigarette smoking, excess body weight, alcohol consumption, physical inactivity, diet, and infections.

11 Jul 2024

New urine-based test holds great promise for early detection and prevention of cervical cancer

Cervical cancer is one of the most common cancers in women, with approximately 660,000 new cases and 350,000 deaths worldwide in 2022 alone.

8 Jul 2024

New study supports expanded access to HPV testing via self-collection

In 2019, more than 12,000 new cases of cervical cancer were diagnosed and upwards of 4,000 patients died in the U.S. The causal link between human papillomavirus (HPV) infection and the development of cervical cancer is well documented. Cervical cancer screening guidelines are currently in the review process for updates. On May 15, 2024, the U.S. Food and Drug Administration (FDA) approved patient-collected testing (vaginal self-collection) for HPV. Several countries, including the Netherlands and Australia, have introduced HPV self-collection as a part of their national screening programs.

3 Jul 2024

Phase III trial highlights benefits of intensity modulated proton therapy for oropharyngeal cancer

According to preliminary data from a multi-institution Phase III trial led by researchers at The University of Texas MD Anderson Cancer Center, intensity modulated proton therapy (IMPT) achieved similar clinical outcomes and offered significant patient benefits when compared to traditional intensity modulated radiation therapy (IMRT) as part of chemoradiation treatment for patients with oropharyngeal (head and neck) cancer.

6 Jun 2024

Canada's plan to eliminate cervical cancer by 2040: HPV-based screening and vaccination key

The impact of three priority actions of the Canadian Partnership Against Cancer (CPAC) on the time to eliminate cervical cancer in British Columbia (BC), Canada.

5 Jun 2024

Researchers develop a simpler and more effective screening method for cervical cancer

Researchers at Karolinska Institutet in Sweden and the University of Innsbruck in Austria have developed a simpler and more effective screening method for cervical cancer than the method used today.

4 Jun 2024

HPV-based screening key to eliminating cervical cancer in Canada

Implementing human papillomavirus (HPV)-based screening in British Columbia could eliminate cervical cancer in the province before 2040, according to a modeling study in CMAJ.

3 Jun 2024

Study shows safety of extended HPV testing intervals in cervical cancer screening

The risk of detecting cervical precancer eight years after a negative human papillomavirus (HPV) screening was found to be similar to the risk after three years (the commonly recommended screening interval) after a negative cytology screening.

22 May 2024

HPV vaccination reduces cervical cancer across all socioeconomic groups in England

The human papillomavirus (HPV) vaccination programme in England has not only been associated with a substantial reduction in cervical disease, but has done so in all socioeconomic groups, finds a study published by The BMJ today.

16 May 2024

Cervical cancer rates drop significantly among vaccinated women

The efficiency of the HPV vaccination program in reducing the prevalence of cervical cancers.

16 May 2024

HPV vaccination rates increase with school entry requirements, study finds

A new study from researchers at Wake Forest University School of Medicine shows that school entry requirements are linked to an increase in human papillomavirus (HPV) vaccinations.

29 Apr 2024

Urine-based test developed for early detection of head and neck tumors

Researchers from the University of Michigan Health Rogel Cancer Center have created a urine-based test that detects pieces of DNA fragments released by head and neck tumors.

16 Apr 2024

New genetic variants could raise a woman's risk of cervical cancer from HPV infections

Human papillomavirus (HPV) is the second most common cancer-causing virus, accounting for 690,000 cervical and other cancers each year worldwide.

12 Apr 2024

ChatGPT could be an effective tool to help reduce vaccine hesitancy

New research being presented at this year's ESCMID Global Congress (formerly ECCMID) in Barcelona, Spain (27-30 April) suggests that the free-to-use, widely accessible ChatGPT could be an effective tool to help reduce vaccine hesitancy among the general public, as well as providing helpful advice on sexually transmitted infections (STIs) in conjunction with sexual health clinics, by improving knowledge and access to care.

10 Apr 2024

Unraveling the complex web of rectal infections and the microbiome in MSM

Study delves into the relationships between various sexually transmitted infections, including Neisseria gonorrhoeae, Chlamydia trachomatis, Torquetenovirus, and high-risk HPV, and their effects on the anorectal microbiome among men who have sex with men (MSM), unveiling complex interactions that may influence infection outcomes and treatment strategies.

10 Apr 2024

Major global commitments announced to eradicate cervical cancer

Governments, donors, multilateral institutions, and partners today announced major new policy, programmatic and financial commitments, including nearly US$ 600 million in new funding, to eliminate cervical cancer.

28 Mar 2024

CRISPR-based diagnostics for rapid oral pathogen detection

A study aiming to develop a low-cost, rapid detection technique for the widescale detection and screening of oral microorganisms suitable for point-of-care settings was presented at the 102nd General Session of the IADR, which was held in conjunction with the 53rd Annual Meeting of the American Association for Dental, Oral, and Craniofacial Research and the 48th Annual Meeting of the Canadian Association for Dental Research, on March 13-16, 2024, in New Orleans, LA, USA.

19 Mar 2024

Human Papillomavirus (HPV) News and Research

Latest Human Papillomavirus (HPV) News and Research

New national guidelines for anal cancer prevention in HIV patients based on UCSF research

Global childhood immunization coverage: Stalled progress and growing gaps

40% of US cancer cases linked to lifestyle choices

Study: 40% of cancer cases in the U.S. attributable to modifiable risk factors

New urine-based test holds great promise for early detection and prevention of cervical cancer

New study supports expanded access to HPV testing via self-collection

Phase III trial highlights benefits of intensity modulated proton therapy for oropharyngeal cancer

Canada's plan to eliminate cervical cancer by 2040: HPV-based screening and vaccination key

Researchers develop a simpler and more effective screening method for cervical cancer

HPV-based screening key to eliminating cervical cancer in Canada

Study shows safety of extended HPV testing intervals in cervical cancer screening

HPV vaccination reduces cervical cancer across all socioeconomic groups in England

Cervical cancer rates drop significantly among vaccinated women

HPV vaccination rates increase with school entry requirements, study finds

Urine-based test developed for early detection of head and neck tumors

New genetic variants could raise a woman's risk of cervical cancer from HPV infections

ChatGPT could be an effective tool to help reduce vaccine hesitancy

Unraveling the complex web of rectal infections and the microbiome in MSM

Major global commitments announced to eradicate cervical cancer

CRISPR-based diagnostics for rapid oral pathogen detection

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Human Papillomavirus (HPV) News and Research

Latest Human Papillomavirus (HPV) News and Research

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in